Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study
Lin CM, Chen JC, Meyerowitz-Katz G, et al.
Diabetes Obes Metab. Pub. online 13 Jan 2025.
Leggi